Optic Nerve Diseases Epidemiology Forecast 2025-2034

The prevalence of optic nerve diseases varies depending on the type of condition. Glaucoma ranks as the most common optic nerve disorder, affecting more than 3 million people in the United States annually. Optic nerve diseases can be caused by developmental or acquired factors.

Optic Nerve Diseases Epidemiology Forecast Report Coverage

The “Optic Nerve Diseases Epidemiology Forecast Report 2025-2034” offers comprehensive information on the prevalence and demographics of optic nerve diseases. It projects the future incidence and prevalence rates of optic nerve diseases across various populations. The study covers age, gender, and type as major determinants of the optic nerve diseases-affected population. The report highlights patterns in the prevalence of optic nerve diseases over time and projects future trends based on multiple variables.

The report provides a comprehensive overview of the disease, as well as historical and projected data on the epidemiology of optic nerve diseases in the 8 major markets.

Regions Covered

• The United States
• Germany
• France
• Italy
• Spain
• The United Kingdom
• Japan
• India

Optic Nerve Disease Overview

Optic nerve diseases include many conditions in which the optic nerve is affected. Blind spots, blurred vision, color blindness, double vision, and eye irritation are some of the symptoms of optic nerve disorders. Optic neuritis is a type of optic nerve disease where infections or the immune system trigger inflammation of the optic nerve. Optic nerve diseases can be a result of developmental factors (genetic or abnormal development) or acquired factors (disease or trauma).

Optic Nerve Diseases: Treatment Overview

Treatments for optic nerve diseases are typically focused on targeting the underlying cause, preventing further damage, and managing symptoms to preserve vision. Glaucoma patients often use eye drops (prostaglandin analogs and beta-blockers) to reduce intraocular pressure. Intravenous or oral corticosteroids (methylprednisolone) are commonly prescribed for optic neuritis to reduce inflammation. Immunotherapy may also be needed for recurrent optic neuritis or associated autoimmune conditions.

Epidemiology

The optic nerve diseases epidemiology section offers information on the patient pool from history to the present as well as the projected trend for each of the 8 major markets. The publisher provides both current and predicted trends for optic nerve diseases by examining a wide range of studies. Additionally, the report covers the diagnosed patient pool for optic nerve diseases and their trends. The data is broken down into specific categories, such as total prevalent cases in males and females, and total diagnosed cases across different age groups and patient pools.

• In the United States, around 4.22 million individuals are suffering from glaucoma, accounting for 1.62% of adults aged 18 and older along with 1.49 million individuals with vision-affecting glaucoma, according to the new study “Prevalence of Glaucoma among US Adults in 2022” published in JAMA Ophthalmology.
• The risk of glaucoma increases with age, with about 1 in 180 adults having vision loss due to this optic nerve disease. Further, approximately 1.94 million males and 2.29 million females are affected by glaucoma.
• As per a population-based study published in Ophthalmology (2022), the total incidence of optic neuritis was estimated to be 5.51 per 100,000 people. In male and female patients, the incidence was reported to be 4.99 and 6.06 per 100,000 people, respectively.
• Nearly 50% of people with multiple sclerosis tend to develop optic neuritis. This optic nerve disease affects both adults and children of all age groups.

Country-wise Optic Nerve Diseases Epidemiology

The optic nerve diseases epidemiology data and findings for the United States, EU-4 (Germany, Spain, Italy, France), the United Kingdom, Japan, and India are also provided in the epidemiology section.

The epidemiology of optic nerve diseases varies between countries owing to the differences in genetics, environmental factors, healthcare access, and disease awareness. Glaucoma is the most common optic nerve disease, with a substantial prevalence in African and Asian populations. Further, in the United States, around 3 million people are affected by glaucoma every year. On the other hand, optic neuritis is closely linked with multiple sclerosis, and thus its incidence is high in regions with higher multiple sclerosis prevalence.

Scope of the Report

• The report covers a detailed analysis of signs and symptoms, causes, risk factors, pathophysiology, diagnosis, treatment options, and classification/types of optic nerve diseases based on several factors.
• Optic Nerve Diseases Epidemiology Forecast Report covers data for the eight major markets (the US, France, Germany, Italy, Spain, the UK, Japan, and India).
• The report helps to identify the patient population and the unmet needs of optic nerve diseases are highlighted along with an assessment of the disease's risk and burden.

Key Questions Answered

• What are the key findings of optic nerve diseases epidemiology in the 8 major markets?
• What will be the total number of patients with optic nerve diseases across the 8 major markets during the forecast period?
• What was the country-wise prevalence of optic nerve diseases in the 8 major markets in the historical period?
• Which country will have the highest number of optic nerve diseases patients during the forecast period of 2025-2034?
• Which key factors would influence the shift in the patient population of optic nerve diseases during the forecast period of 2025-2034?
• What are the currently available treatments for optic nerve diseases?
• What are the disease risks, signs, symptoms, and unmet needs of optic nerve diseases?

This product will be delivered within 3-5 business days.